Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor-Reference-Cited by-同舟云学术

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor

Published:2023-01 Issue:1 Volume:16 Page:36-46
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Franchi Francesco^ORCID,Ortega-Paz Luis,Rollini Fabiana,Galli Mattia^ORCID,Been Latonya,Ghanem Ghussan,Shalhoub Awss,Ossi Tiffany,Rivas Andrea,Zhou Xuan,Pineda Andres M.,Suryadevara Siva,Soffer Daniel,Zenni Martin M.,Reiter Birgit,Jilma Bernd,Angiolillo Dominick J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Effect of platelet inhibition with cangrelor during PCI on ischemic events;Bhatt;N Engl J Med,2013

2. Antiplatelet therapy after percutaneous coronary intervention;Angiolillo;EuroIntervention,2022

3. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Lawton;J Am Coll Cardiol,2022

4. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Collet;Eur Heart J,2021

5. International expert consensus on switching Platelet P2Y12 receptor-inhibiting therapies;Angiolillo;Circulation,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of cangrelor as compared to ticagrelor in patients with ST-elevated myocardial infarction (STEMI): a systematic review and meta-analysis;The Egyptian Heart Journal;2024-04-16

2. Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention;Journal of Thrombosis and Thrombolysis;2024-04-13

3. P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study;JACC: Cardiovascular Interventions;2024-04

4. Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study;IJC Heart & Vasculature;2024-02

5. North American perspective on the 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes;European Heart Journal: Acute Cardiovascular Care;2023-12-13